Asosiy kontentga oʻtish
Maqola

A Validated, Green HPTLC Densitometric Method for Simultaneous Determination of Sodium Alendronate and Cholecalciferol in Combined Tablet Dosage Form: A QbD-Guided Development, Forced Degradation Profiling, and Comparison with RP-HPLC

Neha A. PorwarPriyanka NagarAssociate Professor, University Institute of Pharmacy, Oriental University, IndoreSudha VengurlekarSachin Kumar Jain
2026
ABI

Annotatsiya

Background: High-Performance Thin-Layer Chromatography (HPTLC) offers compelling advantages for pharmaceutical quality control, including exceptional sample throughput (up to 20 samples per plate analyzed simultaneously), minimal solvent consumption (10–20 mL per plate vs. 10–20 mL per injection for HPLC), opensystem architecture enabling post-chromatographic derivatization, and suitability for 'green chemistry' principles. A validated HPTLC method for the simultaneous determination of the antiresorptive-vitamin D pair — Sodium Alendronate (SAL) and Cholecalciferol (CHO) — from their fixed-dose combination (FDC) tablet does not exist in the literature. The absence of such a method represents a significant gap given the growing need for cost-effective QC tools in resource-limited settings and the utility of HPTLC as an orthogonal method. Methods: An Analytical Quality by Design (AQbD) framework was implemented to develop a normal-phase HPTLC method. A Box-Behnken Design (BBD, n=15) was employed to optimize Critical Method Parameters: mobile phase composition, chamber saturation time, application volume, migration distance, and derivatization reagent concentration. The optimized system comprised a normal-phase silica gel 60 F254 aluminum-backed plate with n-Butanol: Glacial Acetic Acid: Water (4:1:0.5, v/v/v) as the mobile phase (BAW system). Dual detection was achieved by densitometric scanning at 265 nm for CHO (direct) and at 520 nm for SAL after post-chromatographic derivatization with 0.2% ninhydrin reagent (110°C, 5 min). Method validation was conducted per ICH Q2(R1). Results: The BAW mobile phase system achieved complete and reproducible separation of SAL (Rf ≈ 0.32 ± 0.02) and CHO (Rf ≈ 0.61 ± 0.02) with excellent band resolution (ΔRf = 0.29). Linearity was established over 200–1200 ng/band for SAL (r = 0.9992) and 20–120 ng/band for CHO (r = 0.9995). Precision: %RSD <1.5% for all parameters. Accuracy: mean recovery of 99.3–100.8% for SAL and 99.0–101.2% for CHO. Forced degradation confirmed the stability-indicating nature, with CHO being labile and SAL exhibiting greater stability. A comprehensive analytical merits comparison with the previously validated RP-HPLC method demonstrated statistically equivalent results (p > 0.05), with HPTLC offering significant advantages in cost-per-sample and environmental sustainability metrics. Conclusion: A novel, validated, green HPTLC-densitometric method for simultaneous determination of SAL and CHO in FDC tablets has been developed using AQbD principles and validated per ICH Q2(R1). The method demonstrates equivalence with the RP-HPLC method while offering substantially greater throughput, lower solvent consumption, and lower cost, making it well-suited for routine QC, particularly in resource-limited environments.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba